- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06170853
The Effect of Exercise With AR Glasses on Metabolic Parameters and Anthropometric Measurements in Obese Adolescents
December 6, 2023 updated by: Harun Özbey, TC Erciyes University
This study was planned as a randomized controlled experimental study to determine the effect of exercise with Augmented Reality Goggles (AR) on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years.
The study will be conducted with children diagnosed with obesity between the ages of 10-19 years who are followed up in the Pediatric Endocrinology Outpatient Clinic of Erciyes University Health Application and Research Center Fevzi Mercan-Mustafa Eraslan Children's Hospital.
According to the sample calculation, a total of 20 obese children aged 10-19 years (AR exercise group=10 and control group=10) will be included in the sample of the study.
The data of the study will be collected using the Descriptive Characteristics Form for Obese Children and Their Families, Serum and Urine Biochemistry Values Form, Anthropometric Measurement Values Form, Augmented Reality Goggles, Body Composition Analyzer, Caliper, Tape Measure and Digital Height and Weight Measurement Device.
Ethics committee permission was obtained from "Erciyes University Clinical Research Ethics Committee" and institutional permission was obtained from ERU Health Practice and Research Center Mustafa Eraslan Fevzi Mercan Children's Hospital.
Hypothesis tests, correlation and regression analyzes will be applied according to the suitability of the data for normal distribution.
As a result of the study, it is expected that exercise application with AR glasses will improve metabolic parameters and anthropometric measurement values in obese children.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Obesity, which is one of the major health problems in both developed and developing countries today, is a health problem that occurs with an increase in adipose tissue when energy intake is higher than energy consumption and can cause social, psychological and serious medical problems.
If current trends continue, it is reported that 70 million children may be obese and overweight by 2025 and obesity will be a leading health problem.
Childhood obesity increases in the first year of life, between 5-6 years of age and during puberty.
1/3 of obese children and 80% of obese adolescents remain obese when they reach adulthood.
On the other hand, it is known that 30% of adult obesity cases date back to childhood.
It has been reported that obesity affects 10.9-20.0% of all children and adolescents.
In a study involving 5206 school-age children (mean age 8.6±1.2 years, 50.2% boys) from seven European countries (Turkey, Bulgaria, Romania, Lithuania, Germany, Italy and the Netherlands), it was reported that the prevalence of obesity in Turkish children was 7.7%, the second highest in Europe after Romania.
Obesity in childhood has many medical adverse effects on children.
Obesity may cause problems such as rapid growth, early menstruation, increase in blood lipids, increase in heart rate and heart rate volume, fatty liver, impaired sugar metabolism, hypertension, increase in white adipose tissue, increase in serum irisin, myonectin, triglyceride, total cholesterol and leptin levels and decrease in omentin-1 levels.
In studies conducted in obese and healthy children, it was found that triglyceride, total cholesterol, irisin, low density lipoprotein (LDL-C) and leptin concentrations were higher in obese children compared to healthy children and omentin-1 levels were lower.
Considering that childhood obesity continues into adulthood and brings many problems, the importance of combating obesity in this period is clearly seen.
Reducing calorie intake, increasing exercise and providing psychosocial support are very important in the fight against obesity.
While exercise constitutes a part of the standard treatment of obesity, it has been reported to be more effective than diet because it increases energy expenditure.
In studies conducted in obese children, it was found that planned and long-term moderate exercise increased serum irisin, myonectin, omentin-1 and HDL concentrations and decreased serum leptin, triglyceride, total cholesterol and LDL concentrations.
It has also been reported that exercise reduces metabolic and cardiovascular complications and improves body composition, cardiovascular health and mental health.
Despite the numerous benefits of exercise, it has been reported that regular exercise habits are low in obese children.
It has been reported that obese children cannot exercise regularly due to reasons such as low motivation, parents' inability to spare time to spend time with their children, children who are overwhelmed between courses/courses in the exam marathon with career anxiety, lack of emotional support and inability to give up existing habits.
In this direction, exercise that requires continuity in the management of childhood obesity can be made dynamic for obese children by using different approaches.
Therefore, it is thought that structured exercise with augmented reality glasses (AR) that can respond to the reactions of the obese child will be more dynamic, improve metabolic and anthropometric values and prevent macrovascular complications that may develop in obese children.
This study was planned as a randomized controlled experimental study to determine the effect of exercise with AR glasses on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Harun Özbey, PhD
- Phone Number: +905446559461
- Email: harunozbey@erciyes.edu.tr
Study Locations
-
-
-
Kayseri, Turkey, 38039
- Recruiting
- Erciyes University
-
Contact:
- Harun Özbey, PhD
- Phone Number: +905446559461
- Email: harunozbey@erciyes.edu.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Those between the ages of 10-19,
- Having been diagnosed with childhood obesity at least six months ago,
- Do not have any other chronic disease,
- No psychiatric diagnosis,
- No orthopedic problems,
- Able to read and write
- Can speak Turkish,
- No mental, physical or neurological disability,
- Residing in the province where the research will be conducted,
- Children and children with parental consent to participate in the study will be included in the study.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
No intervention/application will be made to the children who will be included in the control group.
|
|
Experimental: Augmented reality glasses group
Three days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses.
|
Three days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in serum leptin levels
Time Frame: Change in average serum leptin over 12-week sessions
|
Serum leptin of children with type 1 diabetes before, during, after exercise and during the control session.
|
Change in average serum leptin over 12-week sessions
|
Change in serum irisin levels
Time Frame: Change in average serum irisin over 12-week sessions
|
Serum irisin of children with type 1 diabetes before, during, after exercise and during the control session.
|
Change in average serum irisin over 12-week sessions
|
Change in body mass index
Time Frame: Change in average body mass index over 12-week sessions
|
Average body mass index values of children with obesity before, during, after exercise and during the control session.
|
Change in average body mass index over 12-week sessions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Meral Bayat, PhD, TC Erciyes University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2023
Primary Completion (Estimated)
January 1, 2024
Study Completion (Estimated)
March 1, 2024
Study Registration Dates
First Submitted
December 6, 2023
First Submitted That Met QC Criteria
December 6, 2023
First Posted (Estimated)
December 14, 2023
Study Record Updates
Last Update Posted (Estimated)
December 14, 2023
Last Update Submitted That Met QC Criteria
December 6, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/198
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Obesity
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Vanderbilt University Medical CenterActive, not recruitingPediatric Obesity | Childhood Obesity | Childhood Onset ObesityUnited States
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
-
Universidad Autonoma de San Luis PotosíCompletedChildhood Obesity | Childhood OverweightMexico
Clinical Trials on Exercise with augmented reality glasses
-
TC Erciyes UniversityRecruitingType1diabetes | Metabolic Syndrome | Nursing CariesTurkey
-
Shu-Chen LiaoCompleted
-
National Cancer Center, KoreaUnknown
-
University of ÉvoraFoundation for Science and Technology, Portugal; Comprehensive Health Research...Completed
-
Ardahan UniversityAtaturk UniversityCompletedCopd | Breathing ExercisesTurkey
-
Ruben Fernandez MatiasSuspended
-
Aristotle University Of ThessalonikiNot yet recruitingSpinal Cord InjuriesGreece
-
Aristotle University Of ThessalonikiNot yet recruiting
-
University Hospital, Clermont-FerrandActive, not recruitingMyoma;Uterus | Adenomyoma of UterusFrance
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed